
1. clin liver dis. 2017 nov;21(4):697-707. doi: 10.1016/j.cld.2017.06.003. epub 2017
jul 26.

the liver oncology.

dhanasekaran r(1), kwo py(2).

author information: 
(1)department medicine, stanford university school medicine, 750 welch road
#210, palo alto, ca 94304-1507, usa.
(2)department medicine, stanford university school medicine, 750 welch road
#210, palo alto, ca 94304-1507, usa. electronic address: pkwo@stanford.edu.

gastroenterologists hepatologists encounter oncology patients who
develop abnormal liver tests, patients hepatic malignancies, patients
with acute chronic liver disease require chemotherapy immediate
evaluation. chemotherapy cause liver injury owing toxic effects or
idiosyncratic reactions. immune checkpoint inhibitors may associated with
autoimmune-mediated liver toxicities. venoocclusive disease requires immediate
evaluation. nodular regenerative hyperplasia chronic progressive disorder.
screening prophylaxis reactivation hepatitis b important to
minimize complications patients receiving chemotherapy. patients with
metastatic lesions undergo resection ablation. hepatic injury may occur in
those receiving radiation-based therapies.

copyright Â© 2017 elsevier inc. rights reserved.

doi: 10.1016/j.cld.2017.06.003 
pmid: 28987257  [indexed medline]

